Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Oncology Research|May 10, 2018
Safety and efficacy analysis of DEB-TACE treatment in elderly patients with hepatocellular carcinoma: a comparative cohort studyQing Yang, Xiaosheng Jin, Fangpeng Ye, et al.
Journal of Biomaterials Applications|August 30, 2024
Poly (β-amino esters)/Mobil Composition of Matter 41-mediated delivery of siIL-1β alleviates deep vein thrombosis in rat hind limbsBingru Zheng, Jinjie Chen, Yizhou Xu, et al.
Cancer Biology & Therapy|April 25, 2020
LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinomaChangsheng Shi, Qing Yang, Songsong Pan, et al.
Frontiers in Pediatrics|May 18, 2026
The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trialYing Yuan, Yuqi Deng, Chengcheng Zhu, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|May 8, 2022
Accommodation and vergence function in children using atropine combined with orthokeratologyJinyun Jiang, Wen Long, Yin Hu, et al.
Trials|December 2, 2021
Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trialYing Yuan, Chengcheng Zhu, Mingming Liu, et al.
Laboratory Medicine|October 11, 2018
Expression Analysis of Long Non-Coding RNA HAR1A and HAR1B in HBV-Induced Hepatocullular Carcinoma in Chinese PatientsZhenjing Shi, Ya Luo, Minghui Zhu, et al.
Journal of Nanobiotechnology|June 27, 2023
Nano hydrogel-based oxygen-releasing stem cell transplantation system for treating diabetic footLiangmiao Chen, Bingru Zheng, Yizhou Xu, et al.
The British Journal of Ophthalmology|October 13, 2022
Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trialShengsong Xu, Zhouyue Li, Wenchen Zhao, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|July 23, 2025
Twice-daily administration improves the effectiveness of 0.01% atropine for controlling myopia in slowing axial elongation and refractive progressionShengsong Xu, Mengyi Wang, Yiwen Qu, et al.
Pageof 3